Citations

Mayo Clinic

Showing 10 of 108599 citations.

Cost-effectiveness projections of FOLFOX vs. IFL in first-line therapy of metastatic colorectal cancer in the context of the U.S. health care system
Hillner, Bruce E., Fuchs, Charles S. , Goldberg, Richard M. , Schrag, Deborah , Sargent, Daniel J.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3531-3531

10.1200/jco.2005.23.16_suppl.3531 Get It

Safety and efficacy of panitumumab monotherapy in patients with metastatic colorectal cancer (mCRC)
Malik, Imtiaz A. , Hecht, J. Randolph, Patnaik, A., Croghan, Gary A., Navale, Lynn, MacDonald, Michael R. , Jerian, S., Meropol, Neal J. , Patnaik, Amita , Venook, Alan P. , Berlin, Jordan D.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3520-3520

10.1200/jco.2005.23.16_suppl.3520 Get It

Results of 3rd line therapy on N9841: a randomized phase III trial of oxaliplatin/5-fluorouracil (5FU)/leucovorin (FOLFOX4) versus irinotecan (CPT-11) in patients (pts) with advanced colorectal cancer (CRC) previously treated with prior 5FU chem
Rowland, Kendrith M. , Pitot, Henry C., Philip, P. A., Mitchell, Edith P. , Mailliard, J A, Goldberg, Richard M. , Sargent, Daniel J. , Alberts, Steven R.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3519-3519

10.1200/jco.2005.23.16_suppl.3519 Get It

Endpoints for Colon Adjuvant Clinical Trials (CACT): Recommendations based on individual patient data (IPD) from 20898 patients (pts) and 18 randomized trials
Sargent, Daniel J.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3512-3512

10.1200/jco.2005.23.16_suppl.3512 Get It

Glutathione S-transferase P1 I105V (GSTP1 I105V) polymorphism is associated with early onset of oxaliplatin-induced neurotoxicity
Grothey, Axel, McLeod, H. L., Green, E. M., Ramanathan, Rajesh , Findlay, B., Goldberg, Richard M. , Green, E. M., Sargent, Daniel J. , Fuchs, C., Williamson, Stephen K.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3509-3509

10.1200/jco.2005.23.16_suppl.3509 Get It

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis
Arkenau, Hendrik‐Tobias , Kubicka, Stefan, Kretzschmar, Albrecht , Freier, Werner , Seufferlein, Thomas , Hinke, Axel , Porschen, Rainer, Schmoll, Hans‐Joachim , Graeven, Ullrich , Grothey, Axel

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3507-3507

10.1200/jco.2005.23.16_suppl.3507 Get It

A phase I study of BAY 43–9006 and gefitinib in patients with refractory or recurrent non-small-cell lung cancer (NSCLC)
Adjei, Alex A. , Mandrekar, Sumithra J. , Marks, Randolph S., Hanson, L., Aranguren, Dawn, Jett, James R., Simantov, Ronit, Croghan, Gary A., Schwartz, Brian E.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3067-3067

10.1200/jco.2005.23.16_suppl.3067 Get It

Inhibition of the insulin like growth factor 1 receptor by a specific monoclonal antibody in multiple myeloma
Alsina, Melissa , Lacy, Martha Q. , Poutney, S., Birgin, Ann, Littman, Bruce H., Melvin, C., Petersen, Jane, Gualberto, Antonio

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3048-3048

10.1200/jco.2005.23.16_suppl.3048 Get It

A phase 1–2 clinical study of a second generation oral MEK inhibitor, PD 0325901 in patients with advanced cancer
LoRusso, Patricia , Krishnamurthi, S, Rinehart, John, Nabell, Lisle, Croghan, Gary A., Varterasian, Mary , Sadis, Seth, Menon, Sujatha, Leopold, Judith, Meyer, Mark B.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3011-3011

10.1200/jco.2005.23.16_suppl.3011 Get It

A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors
X., C., Croghan, Gary A., Hanson, L., Mandrekar, Sumithra J. , Marks, Randolph S., Adjei, Alex A. , Furth, Alfred, Reid, Joel M.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3000-3000

10.1200/jco.2005.23.16_suppl.3000 Get It